MLH1 and cancer: We reported the presence of potentially pathogenic variants that could explain the familial predisposition to Lynch syndrome-related tumors without a germline basis of MMR deficiency, including cases with MLH1 methylation, which could support new screening strategies for the identification of families at risk of developing cancer.